Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials Tanya Lewis of […]
Read More… from Here’s What We Know about the Most Touted Drugs Tested for COVID-19
Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials Tanya Lewis of […]
Read More… from Here’s What We Know about the Most Touted Drugs Tested for COVID-19
Matthew Herper writes in STAT that a test for the novel coronavirus that was unveiled by President Trump on the White House […]
Casey Ross writes in STAT that the pitch from technology companies goes something like this: We can tap phone data […]
Read More… from 5 burning questions about tech efforts to track Covid-19 cases
In New York, the curve has started to flatten—but the I.C.U.s are still full, and patients are still dying The […]
Read More… from “It’s Hard to Stay Afloat”: Hope and Exhaustion in the Coronavirus Fight
St. Louis Post-Dispatch Business Columnist David Nicklaus quotes Federal Reserve Bank President James Bullard that universal testing for COVID-19 would […]
Arjen Boin, Allan McConnell and Paul ‘T Hart write in Government Technology that the current global pandemic has upended the […]
Read More… from Leading in a Crisis: How to Navigate the COVID-19 Minefield
The Washington Post fact-checks the public interest in hydroxychloroquine. The world is looking for answers in the search for a […]
Former CDC Director Tom Frieden conducted a comprehensive with STAT on Monday, and it was well worth listening to. Hear […]
Maggie Fox at STAT writes that K.J. Seung is surprised to be hiring and training new workers in Boston. His […]
Dr. Tom Frieden, the former director of the CDC wrote in the New York Times that the organization needs to […]
Read More… from I Used to Run the C.D.C. Here’s What It Can Do to Slow This Pandemic.